TOX4

TOX4 is a chromatin-associated regulatory subunit of a nuclear protein phosphatase 1 (PP1) holoenzyme that controls RNA polymerase II transcription dynamics (PMID:35365735, PMID:40347473). It preferentially binds PP1α and facilitates dephosphorylation of the Pol II CTD on serines 2 and 5 as well as DSIF, thereby restricting pause release and promoting Pol II recycling/reinitiation; loss of TOX4 elevates phosphorylated CTD, reduces promoter Pol II occupancy, and lowers transcriptional output (PMID:35365735). This activity is structurally anchored through a zinc-dependent interaction with the PNUTS TFIIS N-terminal domain on a surface distinct from other TND-binding regulators, and selective disruption of either the PNUTS–TOX4 or PNUTS–PP1 contact impairs gene expression in vivo (PMID:40347473). The same dephosphorylation-dependent reinitiation/elongation control operates in mammalian T cell development, where conditional loss of TOX4 blocks thymocyte development partly through downregulation of Cdk1 (PMID:37286708). TOX4 also acts as a sequence/locus-directed transcriptional activator: it occupies the NTSR1 promoter to drive transcription and promote lung cancer cell migration and invasion, an activity antagonized by the decoy lncRNA SLCO4A1-AS1 (PMID:37726723). Beyond transcription, TOX4 binds platinum-drug-induced DNA adducts and the LEDGF/p75 PWWP domain, the latter contributing to HIV-1 integration (PMID:21184731, PMID:24312278), and it is required during cell-fate reprogramming for enhancer remodeling (PMID:31519808). TOX4 abundance is set by competing inputs: MBD2 binding to CpG islands protects the TOX4 promoter from methylation to activate its expression (PMID:33764669), while the TRIM65 E3 ligase mediates K48-linked ubiquitination and proteasomal degradation of TOX4 (PMID:38212319). Physiologically, TOX4 regulates hepatic glucose production independently of the insulin receptor/AKT-FoxO1 axis and downstream of cAMP/glucocorticoid signaling (PMID:34914893), and it mediates apoptosis in renal tubular and intestinal epithelial injury contexts (PMID:33764669, PMID:38212319).

1. 2010 Medium

   Established a physical activity for TOX4 by showing it directly recognizes platinum-drug DNA adducts, implicating it in the cellular response to DNA damage.

   Evidence Ligand-fishing pulldown from nuclear extracts with nanoHPLC-MS/MS and SPRi binding validation

   PMID:21184731

   Open questions at the time

   • Functional consequence of adduct binding (repair vs. damage signaling) not defined
   • Domain mediating DNA-adduct recognition not mapped
   • No link to its later-defined transcriptional role
2. 2013 Medium

   Placed TOX4 on chromatin via a specific protein interaction by identifying it as a LEDGF/p75 PWWP-domain partner and linking that interaction to HIV-1 integration.

   Evidence Yeast two-hybrid, co-IP, in vitro DNA-dependent binding, co-localization, and HIV-1 vs. MLV integration assays

   PMID:24312278

   Open questions at the time

   • TOX4 region binding the PWWP domain not finely mapped
   • Whether TOX4 directs lentiviral integration site selection unresolved
   • Relationship to PP1/transcription functions unknown
3. 2019 Medium

   Showed TOX4 is functionally required for cell-fate change, acting early in reprogramming to remodel enhancers and assembling into a high-molecular-weight complex.

   Evidence siRNA knockdown during iPSC reprogramming and fibroblast-to-neuron conversion with chromatin accessibility assays and size fractionation

   PMID:31519808

   Open questions at the time

   • Identity of the high-molecular-weight complex not determined
   • Mechanism linking TOX4 to enhancer opening/closing unknown
   • Direct target loci not defined
4. 2021 High

   Defined a physiological role in metabolism, placing TOX4 as an insulin-receptor-independent regulator of hepatic glucose production downstream of cAMP/glucocorticoid signaling.

   Evidence Liver knockout/knockdown in mouse models, glucose tolerance and gluconeogenesis assays, and epistasis with FoxO1 and insulin receptor KO

   PMID:34914893

   Open questions at the time

   • Gluconeogenic target genes directly controlled by TOX4 not enumerated
   • How cAMP/dexamethasone signaling converges on TOX4 unclear
   • Connection to its transcriptional/PP1 mechanism not drawn
5. 2021 Medium

   Identified an upstream transcriptional control of TOX4 itself and a context-specific pro-apoptotic role, showing MBD2 protects the TOX4 promoter from methylation to drive expression.

   Evidence ChIP for MBD2 promoter binding, siRNA knockdown, MBD2 KO mice, and a glycerol-induced AKI model

   PMID:33764669

   Open questions at the time

   • Downstream apoptotic effectors of TOX4 not identified
   • Generality of MBD2 control beyond renal tubular cells unknown
   • Direct vs. indirect role of TOX4 in apoptosis not separated
6. 2022 High

   Resolved the core molecular mechanism: TOX4 directs PP1α-dependent dephosphorylation of the Pol II CTD and DSIF to control pausing, pause release, and reinitiation.

   Evidence ChIP-seq, 4sUDRB-seq, TT-seq, in vitro CTD dephosphorylation assay, and co-IP demonstrating PP1α preference

   PMID:35365735

   Open questions at the time

   • How TOX4 is targeted to specific promoters not defined
   • Stoichiometry/architecture of the TOX4-PNUTS-PP1-WDR82 holoenzyme not resolved here
   • Selectivity for CTD Ser2 vs Ser5 sites mechanistically unexplained
7. 2023 High

   Showed the dephosphorylation-dependent reinitiation/elongation mechanism is physiologically required and conserved, governing mammalian T cell development.

   Evidence Conditional knockout in mice with single-cell RNA-seq, flow cytometry, and Pol II phosphorylation analysis

   PMID:37286708

   Open questions at the time

   • Why CD8 lineage is preferentially affected not fully explained
   • Whether Cdk1 is a direct TOX4 transcriptional target unresolved
   • Cell-type specificity of the requirement not addressed
8. 2023 Medium

   Demonstrated locus-specific transcriptional activation by TOX4 and its regulation by a decoy lncRNA, linking TOX4 to cancer cell invasion via NTSR1.

   Evidence ChIP for promoter occupancy, RNA pulldown and RIP for SLCO4A1-AS1 interaction, and Transwell migration/invasion assays

   PMID:37726723

   Open questions at the time

   • DNA sequence/structural basis of TOX4 promoter binding not defined
   • Whether activation requires PP1/Pol II mechanism unclear
   • Breadth of TOX4 direct target genes not mapped
9. 2024 Medium

   Identified the route to TOX4 protein turnover, showing TRIM65 ubiquitinates and degrades TOX4 to suppress its pro-apoptotic activity in epithelial injury.

   Evidence Yeast two-hybrid, co-IP, K48-linkage ubiquitination assay with a ligase-dead mutant, and functional rescue in hypoxia-reoxygenation injury

   PMID:38212319

   Open questions at the time

   • Signals triggering TRIM65-mediated TOX4 degradation unknown
   • Whether degradation tunes the transcriptional/PP1 function not tested
   • Generality beyond intestinal epithelium unaddressed
10. 2025 High

    Provided the structural basis of TOX4 incorporation into the phosphatase complex, showing a zinc-dependent, distinct-surface contact with the PNUTS TND essential for germline gene expression and fertility.

    Evidence Biochemical binding and structural analysis plus in vivo Drosophila genetics with selective interaction-disrupting mutants and cytological chromosome analysis

    PMID:40347473

    Open questions at the time

    • PNUTS-independent roles of TOX4 not mechanistically defined
    • Conservation of the zinc-dependent binding mode in mammals not directly shown
    • How TOX4 contributes to chromosome dispersal mechanistically unclear

• How TOX4 is recruited to specific genomic loci to reconcile its global Pol II CTD-phosphatase function with locus-specific transcriptional activation (e.g., NTSR1) remains unresolved.
• No defined DNA-binding specificity for TOX4 at activated promoters
• Unclear how the same protein both pauses/recycles Pol II broadly and selectively activates target genes
• Integration of TOX4 abundance control (MBD2, TRIM65) with its transcriptional output not established